Inventor
SEQUEIRA JOEL A
US34 patents
⚠️ This page may combine multiple inventors who share the name “SEQUEIRA JOEL A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
33 patentsUS6057307AMay 2, 2000
Use of mometasone furoate for treating airway passage and lung diseases
SCHERING CORP118 citations98
US5889015AMar 30, 1999
Use of mometasone furoate for treating lower airway passage and lung diseases
SCHERING CORP124 citations98
US5837699ANov 17, 1998
Use of mometasone furoate for treating upper airway passage diseases
SCHERING CORP125 citations98
US5474759ADec 12, 1995
Non-chlorofluorocarbon aerosol formulations
SCHERING CORP180 citations97
US5422361AJun 6, 1995
Stable cream and lotion bases for lipophilic drug compositions
SCHERING CORP138 citations97
US4999189AMar 12, 1991
Sustained release oral suspensions
SCHERING CORP124 citations97
US6723713B2Apr 20, 2004
Use of mometasone furoate for treating upper airway diseases
SCHERING CORP26 citations96
US6677323B2Jan 13, 2004
Use of mometasone furoate for treating airway passage and lung diseases
SCHERING CORP33 citations96
US6677322B2Jan 13, 2004
Use of mometasone furoate for treating airway passage and lung diseases
SCHERING CORP36 citations96
US6365581B1Apr 2, 2002
Use of mometasone furoate for treating airway passage and lung diseases
SCHERING CORP34 citations96
US5186930AFeb 16, 1993
Sustained release oral suspensions
SCHERING CORP70 citations95
US6416743B1Jul 9, 2002
Aerosol formulations of albuterol and 1,1,1,2-tetrafluoroethane
SCHERING CORP53 citations94
US6132758AOct 17, 2000
Stabilized antihistamine syrup
SCHERING CORP56 citations94
US4910205AMar 20, 1990
Transdermal delivery of loratadine
SCHERING CORP52 citations94
US4499108AFeb 12, 1985
Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
SCHERING CORP55 citations94
US6187765B1Feb 13, 2001
Mometasone furoate suspensions for nebulization
SCHERING CORP37 citations93
US4808610AFeb 28, 1989
Mometasone furoate anti-inflammatory cream composition using hexylene glycol
SCHERING CORP26 citations92
US6514520B2Feb 4, 2003
Stabilized antihistamine syrup
SCHERING CORP20 citations91
US6503482B1Jan 7, 2003
Non-chlorofluorocarbon aerosol formulations
SCHERING CORP36 citations91
US4775678AOct 4, 1988
Clotrimazole cream
SCHERING CORP25 citations91
US6068832AMay 30, 2000
Chlorofluorocarbon-free mometasone furoate aerosol formulations
SCHERING CORP44 citations90
US5599557AFeb 4, 1997
Stable hydrated cephalosporin dry powder for oral suspension formulation
SCHERING CORP41 citations89
US4775529AOct 4, 1988
Steroid lotion
SCHERING CORP33 citations89
US4765978AAug 23, 1988
Novel vaginal suppository
SCHERING CORP39 citations87
US6949532B2Sep 27, 2005
Use of mometasone furoate for treating airway passage and lung diseases
SCHERING CORP8 citations82
US6956030B2Oct 18, 2005
Use of mometasone furoate for treating upper airway diseases
SCHERING CORP6 citations73
US4699777AOct 13, 1987
Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea
SCHERING CORP16 citations72
US6790837B2Sep 14, 2004
Ribavirin syrup formulations
SCHERING CORP6 citations70
US4469228ASep 4, 1984
Interferon kit
SCHERING CORP16 citations70
US4489071ADec 18, 1984
Betamethasone dipropionate cream
SCHERING CORP9 citations66
US6939550B2Sep 6, 2005
Stabilized antihistamine syrup
SCHERING CORP3 citations61
US4834980AMay 30, 1989
Transdermal delivery of azatidine
SCHERING CORP1 citations52
US7185647B2Mar 6, 2007
Determination of smoothness of canisters containing inhalable medicaments
SCHERING CORP1 citations39